137 related articles for article (PubMed ID: 34265132)
1. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management.
Hoskins C; Tutty E; Purvis R; Shanahan M; Boussioutas A; Forrest L
J Genet Couns; 2022 Feb; 31(1):242-251. PubMed ID: 34265132
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
3. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.
Liu Y; Calzone K; Fasaye GA; Quillin J
J Genet Couns; 2021 Aug; 30(4):1091-1104. PubMed ID: 33655597
[TBL] [Abstract][Full Text] [Related]
4. Becoming and being a parent with an inherited predisposition to diffuse gastric cancer: A qualitative study of young adults with a
Tutty E; Forbes Shepherd R; Hoskins C; Purvis R; Shanahan M; Boussioutas A; Forrest LE
J Psychosoc Oncol; 2023; 41(3):286-302. PubMed ID: 35959852
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
7. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
8. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
Corso G; Davis JL; Strong VE
J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
[TBL] [Abstract][Full Text] [Related]
9. Decision-making and regret in patients with germline
Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
[TBL] [Abstract][Full Text] [Related]
10. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
11. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
12. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
Gamble LA; Heller T; Davis JL
JAMA Surg; 2021 Apr; 156(4):387-392. PubMed ID: 33404644
[TBL] [Abstract][Full Text] [Related]
14. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
[TBL] [Abstract][Full Text] [Related]
16. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
17. Emerging Adults Carrying a CDH1 Pathogenic or Likely Pathogenic Variant Face Diet and Lifestyle Challenges after Total Gastrectomy.
Liu Y; Lopez R
J Acad Nutr Diet; 2022 May; 122(5):913-917. PubMed ID: 34968751
[TBL] [Abstract][Full Text] [Related]
18. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
Stillman MD; Kusche N; Toledano S; Hilfrank KJ; Yoon C; Gabre JT; Rustgi SD; Hur C; Kastrinos F; Ryeom SW; Yoon SS
J Surg Oncol; 2022 Dec; 126(8):1413-1422. PubMed ID: 36063148
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy after prophylactic total gastrectomy.
Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
[TBL] [Abstract][Full Text] [Related]
20. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]